If you suffer from Type 2 diabetes or hypertension, you should be evaluated for obstructive sleep apnea (OSA) by a physician who is board-certified in sleep medicine. This is a recommendation recently issued for the first time by the American Academy of Sleep Medicine (AASM)
If I’m thin then I’m healthy, right? Wrong. There are several misconceptions people have about weight, losing it and what’s healthy. Here’s the low-down on some myths we’re better off busting.
Scott Scolnick is a sales territory manger for Tandem Diabetes Care, Inc. the insulin pump company which makes the tslim insulin pump. Despite the M.D.’s grim prognosis, he has survived that hurdle and now uses an insulin pump and continuous glucose monitor (CGM) to control his blood glucose levels.
A new study published in the journal Diabetes Care looked at information from more than 1,300 young people. It showed that eating a diet rich in foods containing branched-chain amino acids and long-chain omega-3 fatty acids could keep beta cells functioning longer.
Researchers just reported that skipping breakfast was linked to heart disease (see this week’s Item #5) but a few days later comes word that skipping breakfast could be a good weight-loss strategy because people don’t make up for all those calories later in the day
Kamlesh Khunti, MD, of the University of Leicester in England, and colleagues reported that, in a retrospective study, patients who had an HbA1c of 7% at baseline had a median time to intensification with one additional oral anti-diabetic drug of 2.9 years.
Could a “bionic pancreas”-a combination of insulin pump, continuous glucose monitor and predictive software-be on the market within four years? That 2017 date is the ambitious goal of a project from researchers at Boston University and Massachusetts General Hospital.
Eating foods that contain certain nutrients may help people with newly diagnosed type 1 diabetes continue producing some insulin for as long as two years, a new study finds.
Here we are at the end of another July, and the heat’s been on this past month! Not only in the outside temps across much of the States, but also here in the Diabetes Online Community (DOC). Here’s a roundup of what caught our eye this month, in no particular order
Of about 2,200 people who answered a question about the strips as part of a survey for Diabetes UK, 39% had had prescriptions refused or restricted. It says restrictions are being imposed by local health managers to save money.
A cross-sectional study examined the relationship between obstructive sleep apnea (OAS) and type 2 diabetes (T2DM), and risk factors (obesity, hypertension, and impaired glucose tolerance).
Incidence of severe hypoglycemia was common in 10.8% of diabetic patients surveyed, with rates of hypoglycemia ranging from 9.3% to 13.8% across all levels of HbA1c, according to Kasia Lipska, MD, of Yale University, and colleagues.
This retrospective cohort study determined the effect of colesevelam HCL initiation and A1C level in patients with type 2 diabetes regardless of other anti-diabetic medication use.
In yet another boost to several large drugmakers, the FDA has agreed with European regulators there is no existing evidence to confirm recent concerns that a widely used group of diabetes drugs called GLP-1 inhibitors is linked to pancreatic cancer, an FDA spokeswoman says.
Mice that were fed the drug, called metformin lived about 5 percent longer than those that were not fed the drug. The treated mice lived 160 weeks, while those not taking the drug lived about 150weeks.
Patients with diabetes who take certain types of medications to lower their blood sugar sometimes experience severe low blood-sugar levels, whether or not their diabetes is poorly or well controlled, according to a new study by Kaiser Permanente and Yale University School of Medicine.
A research team led by Nicholas Stylopoulos, HMS assistant professor of pediatrics at Boston Children’s Hospital, has identified the small intestine—widely believed to be a passive organ—as the major contributor to the body’s metabolism, based on a study in rats. The report appears in the July 26, 2013, issue of Science.
Certain diabetes blood sugar testing strips are being recalled by their maker, Nova Diabetes Care, because they may give users false, abnormally high readings, according to the U.S. Food and Drug Administration.
In the early 1930’s, scientists isolated stevioside and rebaudioside, the ingredients that give stevia its sweetness. These ingredients, collectively known as glycosides, are about 300 times sweeter than sugar, but they are calorie-free and carbohydrate-free
My overall impression of the Nova Max is of a good meter that may have a bit of a problem finding an audience. When I started to think about whom Nova Biomedical is selling to, I got stuck. The disparate features of the NovaMax can lead to some identity confusion.